Skip to main content
. 2022 Apr 25;13:840893. doi: 10.3389/fmicb.2022.840893

TABLE 2.

Summary of treatments applied in experimental trials.

Entry Product Plant species Concentration
1 EO Origanum vulgare 300 μg/ml
2 HS Origanum vulgare 1:2 V/V
3 EO Thymus vulgaris 300 μg/ml
4 HS Thymus vulgaris 1:2 V/V
5 EO Rosmarinus officinalis 300 μg/ml
6 HS Rosmarinus officinalis 1:2 V/V
7 Ribavirin N/A 300 μg/ml

Positive (i.e., infected no-treatment plants) and negative (i.e., mock-inoculated plants) controls were also included in each trial.